Neurochemical Research· 2026Q1
Caffeic Acid Regulates High Glucose-Induced Inflammatory Responses in BV-2 Microglial Cells: Implications for Purinergic Signaling
- 0citations
- Q1SCImago
- 2026year
Short summary
Caffeic acid (CA) treatment (50-75 µM) reduced oxidative stress, inflammatory markers (IL-1β, NLRP3, IBA-1), and apoptosis in BV-2 microglial cells exposed to high glucose, while restoring purinergic enzyme activities and modulating purinoceptor densities.
AI-generated from the title and abstract; the full text is not read.
Key points
- Caffeic acid (50-75 µM) reduced oxidative stress markers (NO, RS, TBARS) in high glucose-challenged BV-2 microglial cells.
- CA restored ATP/ADP hydrolysis and modulated adenosine deaminase activity.
- CA treatment altered purinoceptor densities, increasing A1R and decreasing P2X7R and A2AR.
- CA attenuated IL-1β, and at 75 µM, reduced NLRP3 and IBA-1.
- CA decreased apoptosis and promoted cell cycle progression in high glucose conditions.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract High glucose-induced microglial activation contributes to inflammatory processes associated with diabetic complications. Thus, the effects of caffeic acid (CA) on inflammatory responses and purinergic signaling parameters in high glucose-challenged BV-2 microglial cells were investigated. A) Oxidative stress; b) Enzymatic activities of Ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase), Ecto-5-nucleotidase (E-5’-NT), and Adenosine deaminase (ADA); c) Density of P2X7R, A1R, and A2AR purinoceptors; d) Inflammatory markers (IBA-1, NLRP3, and IL-1β); and e) Apoptosis and cell cycle were assessed. Treatment with CA (50 and 75 µM, 24 h) in cells exposed to high glucose medium (GL 25 mM, 48 h) increased viability and reduced nitric oxide (NO), reactive species (RS), and thiobarbituric acid reactive substances (TBARS) levels compared to high glucose-challenged cells. CA also restored ATP and ADP hydrolysis and reduced ADA activity. Furthermore, CA increased the density of the A1R while reversing the high glucose-induced increase in P2X7R and A2AR densities. Moreover, CA treatment attenuated the increase in IL-1β density in high glucose medium, whereas only CA (75 µM) treatment reduced NLRP3 and IBA-1 densities. Besides, this phenolic compound decreased apoptosis and promoted cell cycle progression by increasing the proportion of cells in the S and G2/M phases. Overall, findings suggest that CA attenuates high glucose-induced inflammatory and oxidative alterations in BV-2 microglial cells, besides modulating purinergic enzyme activities and purinoceptor density. These results support the potential involvement of purinergic signaling in the cellular effects of CA and provide possible mechanistic insights into its antioxidant and anti-inflammatory actions under high glucose conditions.
The authors' abstract, as published at the source. Neurochemical Research, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
PhysiologyBiochemistry, Genetics and Molecular Biology